SCO-spondin-derived polypeptides for treating biological barriers dysfunction
AssigneeAxoltis Pharma
InventorsSighild Brunhilde Adeline LEMARCHANT, Yann GODFRIN
Life of this patent
Estimating the term…
Loading patent…
AssigneeAxoltis Pharma
InventorsSighild Brunhilde Adeline LEMARCHANT, Yann GODFRIN
Estimating the term…
The invention concerns polypeptides derived from SCO-spondin for treating a biological barrier dysfunction. More particularly the invention relates to said polypeptides for treating a biological barrier dysfunction in diseases or conditions comprising vascular diseases, infections, immune system hyper-responsiveness, inflammatory diseases or autoimmune diseases, chronic kidney disease, intestinal diseases, macular degeneration, diabetic macular edema, epilepsy, neuropathic pain, CNS diseases and disorders, and aging. The invention also relates to said polypeptides for treating a biological barrier dysfunction in a situation where a disease or condition is absent or not yet diagnosed.
A method for treating a biological barrier dysfunction, or for protecting a biological barrier, in a subject in need thereof, comprising administering to said subject an effective amount of peptide of amino acid sequence
Dependencies are inferred from the claim text.